EAACI guidelines on the management of IgE‐mediated food allergy

• DOI: 10.1111/all.16345
• Publication Date: 2024-10-30T12:51:44Z
• Authors: Alexandra F. Santos; Carmen Riggioni; Ioana Agache; Cezmi A. Akdis; Mubeccel Akdis; Alberto Alvarez‐P...; Montserrat Alvaro...; Barbara Ballmer‐W...; Simona Barni; Kirsten Beyer; Carsten Bindslev‐...; Helen A. Brough; Betul Buyuktiryaki; Derek Chu; Stefano Del Giacco; Audrey Dunn‐Galvin; Bernadette Eberlein; Motohiro Ebisawa; Philippe Eigenmann; Thomas Eiwegger; Mary Feeney; Montserrat Fernan...; Alessandro Fiocchi; Helen R. Fisher; David M. Fleischer; Mattia Giovannini; Claudia Gray; Karin Hoffmann‐So...; Susanne Halken; Jonathan O'B Hour...; Christina J. Jones; Marek Jutel; Edward F. Knol; George N. Konstan...; Gideon Lack; Susanne Lau; Andreina Marques ...; Mary Jane Marchis...; Rosan Meyer; Charlotte G. Mortz; Beatriz Moya; Antonella Muraro; Caroline Nilsson; Lucila Camargo Lo...; Liam O'Mahony; Nikolaos G. Papad...; Kirsten P. Perrett; Rachel Peters; Marcia Podesta; Lars K. Poulsen; Graham Roberts; Hugh Sampson; Jürgen Schwarze; Peter Smith; Elizabeth Tham; Eva Untersmayr; Ronald Van Ree; Carina Venter; Brian Vickery; Berber Vlieg‐Boer...; Thomas Werfel; Margitta Worm; George Du Toit; Isabel Skypala
• Keywords: Guideline; Omalizumab; Peanut Allergy; Egg allergy

This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management IgE-mediated food allergy was developed using Grading Recommendations, Assessment, Development Evaluations (GRADE) approach. Following confirmation diagnosis, allergen avoidance dietary advice (with support a specialised dietitian, if possible) together with provision written treatment plan, education on recognition allergic symptoms prescription medication including adrenaline an auto-injector are essential. Patients significant anxiety requirement coping strategies may benefit from clinical psychologist. As immunomodulatory interventions, omalizumab is suggested in children age 1 adults; oral allergen-specific immunotherapy recommended adolescents peanut milk egg allergies (generally after 4 years egg). Sublingual epicutaneous but not yet available at point care. Future research into disease modifying treatments highly needed, standardised patient-focused protocols outcomes.